Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-13 pm EDT 		5-day change 1st Jan Change
1.15 USD -2.54% Intraday chart for NeuroSense Therapeutics Ltd. -9.45% +46.50%
May. 07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI
Apr. 22 NeuroSense to Collaborate With Genetika+ on Alzheimer's Disease Drug Development; Shares Fall MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. Revisions NeuroSense Therapeutics Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW